Paris based Cellectis therapeutics announced last January that a team of scientists had successfully used its Meganucleases to block an HSV-1 herpes infection. This is the first proof that meganucleses can be used to prevent viral infection.
The implication of this new technique for preventing the spread of virus has the potential to revolutionize [...]